EcoDrugPlus

40s Ribosomal Protein S15-Like

Ensembl ID : ENSSTUG00000044854
Gene Symbol: LOC115156735
3 Cross references
288 Possible Orthologues:

40s Ribosomal Protein S15a

Ensembl ID : ENSSTUG00000036269
Gene Symbol: LOC115147276
3 Cross references
142 Possible Orthologues:

40s Ribosomal Protein S15a-Like

Ensembl ID : ENSSTUG00000047112
Gene Symbol: LOC115177624
3 Cross references
170 Possible Orthologues:

40s Ribosomal Protein S16

Ensembl ID : ENSSTUG00000026299
Gene Symbol: LOC115179980
3 Cross references
305 Possible Orthologues:

40s Ribosomal Protein S16-Like

Ensembl ID : ENSSTUG00000032534
Gene Symbol: LOC115198981
3 Cross references
306 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSSTUG00000041341
Gene Symbol: LOC115177464
3 Cross references
298 Possible Orthologues:

40s Ribosomal Protein S19-Like

Ensembl ID : ENSSTUG00000029049
Gene Symbol: LOC115183127
3 Cross references
301 Possible Orthologues:

40s Ribosomal Protein S2

Ensembl ID : ENSSTUG00000009503
Gene Symbol: LOC115205868
3 Cross references
507 Possible Orthologues:

40s Ribosomal Protein S23

Ensembl ID : ENSSTUG00000027873
Gene Symbol: LOC115168497
3 Cross references
370 Possible Orthologues:

40s Ribosomal Protein S23

Ensembl ID : ENSSTUG00000026351
Gene Symbol: LOC115151038
3 Cross references
371 Possible Orthologues:

40s Ribosomal Protein S23

Ensembl ID : ENSSTUG00000018173
Gene Symbol: LOC115207385
3 Cross references
365 Possible Orthologues:

40s Ribosomal Protein S24

Ensembl ID : ENSSTUG00000008396
Gene Symbol: LOC115153341
3 Cross references
482 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).